Yii-Der Chen, None;
Xiuqing Guo, None;
Radha Ayyagari, None;
Linda Zangwill, Carl Zeiss Meditec, Inc (F), Heidelberg Engineering GmbH, (F), Optovue Inc (F), Topcon Medical System Inc (F);
Jeffrey Liebmann, Alcon, Inc. (C), Allergan, Inc (C), Bausch & Lomb, Inc (F), Bausch & Lomb, Inc (C), Carl Zeiss Meditech, Inc (F), Carl Zeiss Meditech, Inc (C), Heidelberg Engineering, GmbH (F), Heidelberg Engineering, GmbH (C), National Eye Institute (F), Optovue, Inc (F), Reichert, Inc (F), Reichert, Inc (C), Topcon, Inc (F), Valeant Pharmaceutiicals, Inc (C);
Christopher Girkin, Carl Zeiss Meditech, Inc (F), EyeSight Foundation of Alabama (F), Heidelberg Engineering, GmbH (F), National Eye Institute (F), Research to Prevent Blindness (F), SOLX (F);
Robert Feldman, None;
Harvey Dubiner, None;
Jerome Rotter, None;
Robert Weinreb, Alcon, Inc. (C), Allergan, Inc (C), bausch & Lomb, Inc (C), Carl Zeiss Meditec (F), carl Zeiss Meditech, Inc (C), Genentech (F), Heidelberg Engineering (F), Optovue (F), topcon (C), Topcon (F)